Labcorp Holdings EPS - Earnings per Share 2010-2025 | LH
Labcorp Holdings annual and quarterly earnings per share history from 2010 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Labcorp Holdings EPS for the quarter ending March 31, 2025 was $2.52, a 6.32% decline year-over-year.
- Labcorp Holdings EPS for the twelve months ending March 31, 2025 was $8.67, a 71.01% increase year-over-year.
- Labcorp Holdings 2024 annual EPS was $8.84, a 85.32% increase from 2023.
- Labcorp Holdings 2023 annual EPS was $4.77, a 65.86% decline from 2022.
- Labcorp Holdings 2022 annual EPS was $13.97, a 42.72% decline from 2021.
| Labcorp Holdings Annual EPS | |
|---|---|
| 2024 | $8.84 |
| 2023 | $4.77 |
| 2022 | $13.97 |
| 2021 | $24.39 |
| 2020 | $15.88 |
| 2019 | $8.35 |
| 2018 | $8.61 |
| 2017 | $11.81 |
| 2016 | $6.82 |
| 2015 | $4.35 |
| 2014 | $5.91 |
| 2013 | $6.25 |
| 2012 | $5.99 |
| 2011 | $5.11 |
| 2010 | $5.29 |
| 2009 | $4.98 |
| Labcorp Holdings Quarterly EPS | |
|---|---|
| 2025-03-31 | $2.52 |
| 2024-12-31 | $1.72 |
| 2024-09-30 | $2.00 |
| 2024-06-30 | $2.43 |
| 2024-03-31 | $2.69 |
| 2023-12-31 | $-1.85 |
| 2023-09-30 | $2.11 |
| 2023-06-30 | $2.12 |
| 2023-03-31 | $2.39 |
| 2022-12-31 | $0.97 |
| 2022-09-30 | $3.90 |
| 2022-06-30 | $3.87 |
| 2022-03-31 | $5.23 |
| 2021-12-31 | $5.76 |
| 2021-09-30 | $6.05 |
| 2021-06-30 | $4.76 |
| 2021-03-31 | $7.82 |
| 2020-12-31 | $9.61 |
| 2020-09-30 | $7.17 |
| 2020-06-30 | $2.37 |
| 2020-03-31 | $-3.27 |
| 2019-12-31 | $2.31 |
| 2019-09-30 | $2.25 |
| 2019-06-30 | $1.93 |
| 2019-03-31 | $1.86 |
| 2018-12-31 | $1.57 |
| 2018-09-30 | $3.10 |
| 2018-06-30 | $2.27 |
| 2018-03-31 | $1.67 |
| 2017-12-31 | $6.63 |
| 2017-09-30 | $1.65 |
| 2017-06-30 | $1.78 |
| 2017-03-31 | $1.75 |
| 2016-12-31 | $1.57 |
| 2016-09-30 | $1.71 |
| 2016-06-30 | $1.96 |
| 2016-03-31 | $1.58 |
| 2015-12-31 | $1.15 |
| 2015-09-30 | $1.50 |
| 2015-06-30 | $1.66 |
| 2015-03-31 | $0.04 |
| 2014-12-31 | $1.37 |
| 2014-09-30 | $1.59 |
| 2014-06-30 | $1.64 |
| 2014-03-31 | $1.31 |
| 2013-12-31 | $1.44 |
| 2013-09-30 | $1.63 |
| 2013-06-30 | $1.62 |
| 2013-03-31 | $1.56 |
| 2012-12-31 | $1.27 |
| 2012-09-30 | $1.53 |
| 2012-06-30 | $1.56 |
| 2012-03-31 | $1.63 |
| 2011-12-31 | $1.37 |
| 2011-09-30 | $1.31 |
| 2011-06-30 | $1.20 |
| 2011-03-31 | $1.23 |
| 2010-12-31 | $1.24 |
| 2010-09-30 | $1.34 |
| 2010-06-30 | $1.46 |
| 2010-03-31 | $1.25 |
| 2009-12-31 | $1.31 |
| 2009-09-30 | $1.21 |
| 2009-06-30 | $1.24 |
| 2009-03-31 | $1.22 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $21.849B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.515B | 26.35 |
| CVS Health (CVS) | United States | $84.516B | 10.51 |
| Elevance Health (ELV) | United States | $84.143B | 10.86 |
| Cencora (COR) | United States | $56.815B | 19.77 |
| Natera (NTRA) | United States | $23.263B | 0.00 |
| DiDi Global (DIDIY) | China | $22.732B | 24.15 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.354B | 0.00 |
| CochLear (CHEOY) | Australia | $12.742B | 0.00 |
| Solventum (SOLV) | United States | $12.673B | 13.42 |
| ICON (ICLR) | Ireland | $11.895B | 11.06 |
| Revvity (RVTY) | United States | $11.192B | 19.26 |
| Viatris (VTRS) | United States | $10.387B | 3.57 |
| Avantor (AVTR) | United States | $9.152B | 13.30 |
| Medpace Holdings (MEDP) | United States | $8.871B | 23.56 |
| HealthEquity (HQY) | United States | $8.752B | 38.34 |
| Sonic Healthcare (SKHHY) | Australia | $8.201B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.239B | 14.19 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.245B | 25.00 |
| BrightSpring Health Services (BTSG) | United States | $4.003B | 36.73 |
| Sotera Health (SHC) | United States | $3.148B | 17.89 |
| Alignment Healthcare (ALHC) | United States | $2.764B | 0.00 |
| Concentras Parent (CON) | United States | $2.689B | 15.54 |
| Surgery Partners (SGRY) | United States | $2.589B | 33.67 |
| Organon (OGN) | United States | $2.548B | 2.71 |
| GeneDx Holdings (WGS) | United States | $2.274B | 87.59 |
| PACS (PACS) | United States | $1.943B | 0.00 |
| Ardent Health (ARDT) | United States | $1.851B | 7.89 |
| Premier (PINC) | United States | $1.802B | 13.68 |
| Progyny (PGNY) | United States | $1.782B | 39.23 |
| GoodRx Holdings (GDRX) | United States | $1.675B | 33.50 |
| Teladoc Health (TDOC) | United States | $1.384B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.149B | 8.74 |
| Establishment Labs Holdings (ESTA) | $1.058B | 0.00 | |
| CareDx (CDNA) | United States | $1.055B | 16.48 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.999B | 0.00 |
| Agilon Health (AGL) | United States | $0.890B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.811B | 7.59 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| LifeMD (LFMD) | United States | $0.650B | 0.00 |
| Nutex Health (NUTX) | United States | $0.649B | 9.83 |
| Embecta (EMBC) | United States | $0.574B | 3.87 |
| InnovAge Holding (INNV) | United States | $0.536B | 0.00 |
| Enhabit (EHAB) | United States | $0.470B | 38.67 |
| Auna S.A (AUNA) | Luxembourg | $0.463B | 10.42 |
| Sonida Senior Living (SNDA) | United States | $0.457B | 0.00 |
| SBC Medicals (SBC) | United States | $0.450B | 0.00 |
| Omada Health (OMDA) | $0.382B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.281B | 0.00 |
| Beauty Health (SKIN) | United States | $0.243B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.220B | 0.00 |
| Oncology Institute (TOI) | United States | $0.204B | 0.00 |
| DocGo (DCGO) | United States | $0.172B | 28.17 |
| So-Young (SY) | China | $0.168B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.130B | 0.00 |
| OncoCyte (IMDX) | United States | $0.105B | 0.00 |
| KindlyMD (NAKA) | United States | $0.098B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.070B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.051B | 0.00 |
| ModivCare (MODV) | United States | $0.049B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.044B | 0.00 |
| Biodesix (BDSX) | United States | $0.039B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |